Literature DB >> 25954377

Disease progression subtype discovery from longitudinal EMR data with a majority of missing values and unknown initial time points.

Ilkka Huopaniemi1, Girish Nadkarni1, Rajiv Nadukuru1, Vaneet Lotay1, Steve Ellis1, Omri Gottesman1, Erwin P Bottinger1.   

Abstract

Electronic medical records (EMR) contain a longitudinal collection of laboratory data that contains valuable phenotypic information on disease progression of a large collection of patients. These data can be potentially used in medical research or patient care; finding disease progression subtypes is a particularly important application. There are, however, two significant difficulties in utilizing this data for statistical analysis: (a) a large proportion of data is missing and (b) patients are in very different stages of disease progression and there are no well-defined start points of the time series. We present a Bayesian machine learning model that overcomes these difficulties. The method can use highly incomplete time-series measurement of varying lengths, it aligns together similar trajectories in different phases and is capable of finding consistent disease progression subtypes. We demonstrate the method on finding chronic kidney disease progression subtypes.

Entities:  

Mesh:

Year:  2014        PMID: 25954377      PMCID: PMC4419979     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  17 in total

Review 1.  Role of anemia in progression of chronic kidney disease.

Authors:  Jerome Rossert; Marc Froissart
Journal:  Semin Nephrol       Date:  2006-07       Impact factor: 5.299

2.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

3.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

4.  A predictive model for progression of chronic kidney disease to kidney failure.

Authors:  Navdeep Tangri; Lesley A Stevens; John Griffith; Hocine Tighiouart; Ognjenka Djurdjev; David Naimark; Adeera Levin; Andrew S Levey
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

5.  Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography.

Authors:  Matthew T James; William A Ghali; Merril L Knudtson; Pietro Ravani; Marcello Tonelli; Peter Faris; Neesh Pannu; Braden J Manns; Scott W Klarenbach; Brenda R Hemmelgarn
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

6.  Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data.

Authors:  R L Chaiken; M Eckert-Norton; M Bard; M A Banerji; J Palmisano; I Sachimechi; H E Lebovitz
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

Review 7.  Chronic kidney disease, heart failure and anemia.

Authors:  Sean A Virani; Amit Khosla; Adeera Levin
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

8.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Authors:  Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

9.  Long-term prognosis of acute kidney injury after acute myocardial infarction.

Authors:  Chirag R Parikh; Steven G Coca; Yongfei Wang; Frederick A Masoudi; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2008-05-12

10.  Multiple loci associated with indices of renal function and chronic kidney disease.

Authors:  Anna Köttgen; Nicole L Glazer; Abbas Dehghan; Shih-Jen Hwang; Ronit Katz; Man Li; Qiong Yang; Vilmundur Gudnason; Lenore J Launer; Tamara B Harris; Albert V Smith; Dan E Arking; Brad C Astor; Eric Boerwinkle; Georg B Ehret; Ingo Ruczinski; Robert B Scharpf; Yii-Der Ida Chen; Ian H de Boer; Talin Haritunians; Thomas Lumley; Mark Sarnak; David Siscovick; Emelia J Benjamin; Daniel Levy; Ashish Upadhyay; Yurii S Aulchenko; Albert Hofman; Fernando Rivadeneira; André G Uitterlinden; Cornelia M van Duijn; Daniel I Chasman; Guillaume Paré; Paul M Ridker; W H Linda Kao; Jacqueline C Witteman; Josef Coresh; Michael G Shlipak; Caroline S Fox
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

View more
  4 in total

Review 1.  Personalized Medicine and the Power of Electronic Health Records.

Authors:  Noura S Abul-Husn; Eimear E Kenny
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

2.  Initial Validation of a Machine Learning-Derived Prognostic Test (KidneyIntelX) Integrating Biomarkers and Electronic Health Record Data To Predict Longitudinal Kidney Outcomes.

Authors:  Kinsuk Chauhan; Girish N Nadkarni; Fergus Fleming; James McCullough; Cijiang J He; John Quackenbush; Barbara Murphy; Michael J Donovan; Steven G Coca; Joseph V Bonventre
Journal:  Kidney360       Date:  2020-06-30

3.  Inferring the Interactions of Risk Factors from EHRs.

Authors:  Travis Goodwin; Sanda M Harabagiu
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2016-07-19

Review 4.  Applications of machine learning methods in kidney disease: hope or hype?

Authors:  Lili Chan; Akhil Vaid; Girish N Nadkarni
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-05       Impact factor: 3.416

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.